146 related articles for article (PubMed ID: 18592070)
21. Molecular epidemiology of genital human papillomavirus and Chlamydia trachomatis among patients attending a genitourinary medicine clinic - will vaccines protect?
Jalal H; Stephen H; Bibby DF; Sonnex C; Carne CA
Int J STD AIDS; 2007 Sep; 18(9):617-21. PubMed ID: 17785006
[TBL] [Abstract][Full Text] [Related]
22. Merck hopes to extend gardasil vaccine to men.
Chitale R
J Natl Cancer Inst; 2009 Feb; 101(4):222-3. PubMed ID: 19211446
[No Abstract] [Full Text] [Related]
23. Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men.
Kim JJ
J Infect Dis; 2007 Oct; 196(8):1117-9. PubMed ID: 17955427
[No Abstract] [Full Text] [Related]
24. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
25. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
26. Coinfection of Chlamydia trachomatis, Ureaplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia.
Denks K; Spaeth EL; Jõers K; Randoja R; Talpsep T; Ustav M; Kurg R
Scand J Infect Dis; 2007; 39(8):714-8. PubMed ID: 17654349
[TBL] [Abstract][Full Text] [Related]
27. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
28. Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats.
Wise LD; Wolf JJ; Kaplanski CV; Pauley CJ; Ledwith BJ
Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):561-72. PubMed ID: 19025783
[TBL] [Abstract][Full Text] [Related]
29. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
30. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
[TBL] [Abstract][Full Text] [Related]
32. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
Brown DR; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Joura EA; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Sings HL; James M; Hesley TM; Barr E
J Infect Dis; 2009 Apr; 199(7):926-35. PubMed ID: 19236279
[TBL] [Abstract][Full Text] [Related]
33. Human papilloma virus vaccine: a new frontier or political controversy?
Forman SF; Woods ER
Curr Opin Pediatr; 2007 Aug; 19(4):387-8. PubMed ID: 17630600
[No Abstract] [Full Text] [Related]
34. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus, cervical cancer, and the vaccines.
Tovar JM; Bazaldua OV; Vargas L; Reile E
Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
[TBL] [Abstract][Full Text] [Related]
36. Assessing the HPV vaccine: researchers confront complex interplay of factors.
Tuma RS
J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636
[No Abstract] [Full Text] [Related]
37. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
38. Education about human papillomavirus and human papillomavirus vaccines in adolescents.
Kollar LM; Kahn JA
Curr Opin Obstet Gynecol; 2008 Oct; 20(5):479-83. PubMed ID: 18797272
[TBL] [Abstract][Full Text] [Related]
39. Screening for chlamydia with the Pap test.
Toyne H; Glasgow N; McGuiness C; Bowden FJ; Currie MJ
Aust Fam Physician; 2006 Sep; 35(9):743-4. PubMed ID: 16969449
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus infections and vulvar disease development.
Garland SM; Insinga RP; Sings HL; Haupt RM; Joura EA
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1777-84. PubMed ID: 19505910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
